These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38510874)

  • 1. Drug-Induced Liver Injury Secondary to Terbinafine Use.
    Brown A; Potesta M; Hameed A
    Cureus; 2024 Feb; 16(2):e54453. PubMed ID: 38510874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terbinafine-Induced Liver Injury: A Case Report.
    Jilani M; Zaidi S; Cazares Parson M; Brockman MJ; Hakim N; Edwards BP
    Cureus; 2023 Dec; 15(12):e50749. PubMed ID: 38239534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.
    Paredes AH; Lewis JH
    Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Androgen Receptor Modulators (SARMs)-Induced Liver Injury: A Case Report and Review of Literature.
    Mohamed WT; Jahagirdar V; Fatima I; Ahmed MK; Jaber F; Wang K; Hassan A; Ewing E; Clarkston W; Likhitsup A
    Cureus; 2023 Feb; 15(2):e35094. PubMed ID: 36945289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine.
    Fontana RJ; Cirulli ET; Gu J; Kleiner D; Ostrov D; Phillips E; Schutte R; Barnhart H; Chalasani N; Watkins PB; Hoofnagle JH
    J Hepatol; 2018 Dec; 69(6):1317-1325. PubMed ID: 30138689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terbinafine-induced hepatic dysfunction.
    Chambers WM; Millar A; Jain S; Burroughs AK
    Eur J Gastroenterol Hepatol; 2001 Sep; 13(9):1115-8. PubMed ID: 11564966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
    Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
    Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of Progressive Cholestatic Drug-Induced Liver Injury Due to Terbinafine.
    Ley D; Musto J; Said A
    WMJ; 2023 May; 122(2):138-142. PubMed ID: 37141482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mastabol induced acute cholestasis: A case report.
    Hymel BM; Victor DW; Alvarez L; Shores NJ; Balart LA
    World J Hepatol; 2013 Mar; 5(3):133-6. PubMed ID: 23556046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terbinafine-associated hepatic injury.
    van 't Wout JW; Herrmann WA; de Vries RA; Stricker BH
    J Hepatol; 1994 Jul; 21(1):115-7. PubMed ID: 7963410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced liver injury.
    Leise MD; Poterucha JJ; Talwalkar JA
    Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation of terbinafine-induced severe liver injury and the value of laboratory monitoring: a Critically Appraised Topic.
    Kramer ON; Albrecht J
    Br J Dermatol; 2017 Nov; 177(5):1279-1284. PubMed ID: 28762471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Terbinafine-induced liver toxicity in the context of a SARS-CoV-2 pandemic: a case report].
    Bustios Sanchez C; Sumire Umeres J; Asato Higa C; Monge Zapata V
    Rev Gastroenterol Peru; 2021; 41(2):107-111. PubMed ID: 34724692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Cholestatic Liver Injury From Hydralazine Intake.
    Harati H; Rahmani M; Taghizadeh S
    Am J Ther; 2016; 23(5):e1211-4. PubMed ID: 26291593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydralazine-induced cholestatic hepatitis.
    Hassan A; Hammad R; Cucco R; Niranjan S
    Am J Ther; 2009; 16(4):371-3. PubMed ID: 19092641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kratom-Induced Cholestatic Liver Injury and Its Conservative Management.
    Fernandes CT; Iqbal U; Tighe SP; Ahmed A
    J Investig Med High Impact Case Rep; 2019; 7():2324709619836138. PubMed ID: 30920318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Drug-Induced Liver Injury from Labetalol during the Postpartum Period: A Case Report.
    Lee B; Xiong S; Westen EA; Warner JA
    AJP Rep; 2024 Jan; 14(1):e43-e47. PubMed ID: 38269129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation.
    Sembera S; Lammert C; Talwalkar JA; Sanderson SO; Poterucha JJ; Hay JE; Wiesner RH; Gores GJ; Rosen CB; Heimbach JK; Charlton MR
    Liver Transpl; 2012 Jul; 18(7):803-10. PubMed ID: 22389256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophagocytic Lymphohistiocytosis and Pancreatic Cancer: A Rare Association.
    Jaan A; Khalid F; Firoze Ahmed AM; Salman A; Meghal T; Du D
    J Community Hosp Intern Med Perspect; 2023; 13(5):68-71. PubMed ID: 37868670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terbinafine hepatotoxicity. A case report and review of literature.
    Zapata Garrido AJ; Romo AC; Padilla FB
    Ann Hepatol; 2003; 2(1):47-51. PubMed ID: 15094707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.